Gabapentin Tablet, Film Coated
Product Images NDC 63187-148

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Gabapentin (NDC 63187-148). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 1 (Gabapentin Fig1)

A line graph comparing mean pain scores over 8 weeks between placebo and Gabapentin 3600 mg/day. It shows a 4-week dose titration period followed by a 4-week fixed dose period. The Gabapentin group demonstrates a decreasing trend in pain scores, marked with statistical significance (p < 0.01) at multiple time points, compared to a stable trend in the placebo group.*

FDA Label Image

Figure 2. Weekly Mean Pain Scores (observed Cases In Itt Population): Study 2 (Gabapentin Fig2)

A line graph showing mean pain scores over a 7-week period, including a 3-week dose titration and a 4-week fixed dose period. The graph compares placebo with gabapentin at doses of 1800 mg/day and 2400 mg/day, illustrating a decrease in pain scores over time for gabapentin groups compared to placebo. Statistical significance is noted with p < 0.01 at several points.*

FDA Label Image

Figure 3. Proportion Of Responders (patients With ≥50% Reduction In Pain Score) At Endpoint: Controlled Phn Studies (Gabapentin Fig3)

A bar chart comparing the percentage of responders at endpoint between placebo (PBO) and Gabapentin (GBP) at various dosages across two studies. Study 1 shows 12% responders for PBO and 29% for GBP 3600 mg. Study 2 shows 14% responders for PBO and higher percentages for GBP 1800 mg (32%) and 2400 mg (34%). Statistical significance is indicated with asterisks for GBP groups compared to placebo.*

FDA Label Image

Figure 4. Responder Rate In Patients Receiving Gabapentin Expressed As A Difference From Placebo By Dose And Study: Adjunctive Therapy Studies In Patients ≥12 Years Of Age With Partial Seizures (Gabapentin Fig4)

A scatter plot chart showing the percentage difference on the vertical axis versus daily dose in mg on the horizontal axis, comparing results from three studies labeled as STUDY a, STUDY b, and STUDY c. The chart includes black, gray, and white square markers representing each study's data points at various doses ranging from approximately 600 mg to 1800 mg.*

FDA Label Image

Gabapentin 800mg (Gabapentin Fig5)

This is a description of a medication identified as Gabapentin 800mg. The medication comes in a bottle with 90 biconvex, elliptical, white, film-coated tablets, and each tablet contains Gabapentin USP 800mg. The tablets have a break line on both sides with ‘D’ and ‘25’ on either side of the break line on one side and plain on the other side. The NDC for the medication is 63187-148-90, and the product ID is PG014890. It is RX-only medication manufactured by Aurobindo Pharma Limited Unit-VII in India. The medication should be stored at 20°-25°C (68°-77°F), and it is important to keep it out of the reach of children. The lot number is 00000, and the expiration date is 00/00/00. The medication was packaged by Proficient Rx LP in Thousand Oaks, CA 91320.*

FDA Label Image

Chemical Structure (Gabapentin Str)

Chemical structure of gabapentin, showing a cyclohexane ring with attached amino and acetic acid functional groups, representing the active ingredient gabapentin.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.